Lost password ?
Gulf Pharmaceutical
JULPHAR, ATTRACTIVE SHOT IN CLOUDY DAYS
Sep 30 - After jumping to its 44-month high in last January, Gulf Pharmaceutical (Buy, UAE)’s share price dropped by 34.4% pulled down by the modest growth achieved in 2023 and in early 2024. The growth ...
Executive summary
Conflict of Interest
Pages 40
Language English
Publish on September 30, 2024
€ 500
VAT Exl.
You might be also interested by these reports :
FIND A REPORT
CONCEPT
Each company is researched in depth using a structured robust and transparent process.

AlphaMena provides analyses based upon exhaustive and homogeneous information which allows to compare stocks geographically, sector-wise, and by thematic.

The analyses include actuarial as well as off balance-sheet data.